Kenvue Inc., the consumer health company spun off from Johnson & Johnson, announced the resignation of its CEO, Thibaut Mongon. Kirk Perry, former Procter & Gamble executive, will serve as interim CEO. This follows the recent replacement of the CFO and comes amid pressure from activist investors. Kenvue is undergoing a strategic review, potentially involving the sale of some brands to improve profitability, and expects to report Q2 earnings on August 7th.

Prepared by Christopher Adams and reviewed by editorial team.